Domain Associates
Venture Capital
Active
San Diego, United States
308
25M
153
7.90
46
0.50
85
- Stages of investment
- Areas of investment
Summary
Domain Associates appeared to be the VC, which was created in 1985. The main office of represented VC is situated in the San Diego. The venture was found in North America in United States.
Besides them, we counted 9 critical employees of this fund in our database.
The fund has exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Health Diagnostics, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Pharmion, Santarus, Tobira Therapeutics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The increased amount of exits for fund were in 2014. The fund is constantly included in 7-12 deals per year. Comparing to the other companies, this Domain Associates performs on 3 percentage points less the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. When the investment is from Domain Associates the average startup value is 50-100 millions dollars. The high activity for fund was in 2012. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 1 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Domain Associates, startups are often financed by Montreux Equity Partners, Johnson & Johnson Development Corporation, Venrock. The meaningful sponsors for the fund in investment in the same round are Morgenthaler Ventures, Venrock, MPM Capital. In the next rounds fund is usually obtained by Kleiner Perkins, Johnson & Johnson Development Corporation, Canaan Partners.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 308
- Lead investments
- 46
- Exits
- 85
- Rounds per year
- 7.90
- Follow on index
- 0.50
- Investments by industry
- Biotechnology (236)
- Health Care (229)
- Medical (139)
- Pharmaceutical (81)
- Medical Device (76) Show 38 more
- Investments by region
-
- United States (292)
- Canada (5)
- Ireland (1)
- China (1)
- Estonia (1) Show 2 more
- Peak activity year
- 2012
- Number of Unicorns
- 4
- Number of Decacorns
- 4
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Avg. valuation at time of investment
- 128M
- Group Appearance index
- 0.94
- Avg. company exit year
- 9
- Avg. multiplicator
- 2.89
- Strategy success index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Loco Adventures | 10 Jul 2019 | Internet, Augmented Reality, Location Based Services, Gamification | Seed | 158K | Berlin, Germany |
Orexigen Therapeutics | 01 Apr 2005 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 35M | United States, California, San Diego |
Singular Genomics | 01 Jan 2020 | Biotechnology, Health Care, Medical | Early Stage Venture | 45M | United States, California, San Diego |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.